Compressor/nebulizers differences in the nebulization of corticosteroids. The CODE study (Corticosteroids and Devices Efficiency)

European Review for Medical and Pharmacological Sciences

Volumn 11, Issue 4, 2007, Pages 225-237

  Terzano, C ^a   Petroianni, A ^a   Parola, D ^a   Ricci, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aerosol therapy; Corticosteroids; Inhaled drugs; Nebulizer

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLIXOTIDE NEBULES; FLUNISOLIDE; FLUTICASONE PROPIONATE; NISOLID; PULMAXAN AEROSOL; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG RESPONSE; HUMAN; INHALER; INTERMETHOD COMPARISON; NEBULIZATION; NEBULIZER; PARTICLE SIZE; RESPIRATORY TRACT DISEASE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AEROSOLS; ANDROSTADIENES; BECLOMETHASONE; BUDESONIDE; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FLUOCINOLONE ACETONIDE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TIME FACTORS; VOLATILIZATION;

EID: 34748878935     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. MARCUS P, OPPENHEIMER EA, PATEL PA, KATZ LM, DOYLE JJ. Use of nebulized inhaled corticosteroids among older adult patients: An assessment of outcomes. Ann Allergy Asthma Immunol 2006; 96: 736-743.
2. HESS D, FISHER D, WILLIAMS P, POOLER S, KACMAREK RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996; 110; 498-505.
3. TERZANO C. Nebulizzatori. In: C. Terzano, F. Mannino editori. Aerosol - Caratteristiche, analisi, applicazioni terapeutiche. Milano, McGrawHill, 1997; 59-65.
4. TERZANO C, MANNNINO F. Aerosol characterization of three corticosteroid metered dose inhalers with volumatic holding chambers and metered dose inhalers alone at two inspiratory flow rates. J Aerosol Med 1999; 12: 249-254.
5. LOFFERT DT, IKLE D, NELSON HS. A comparison of commercial jet nebulizers. Chest 1994; 106: 1788-1793.
6. TERZANO C, ALLEGRA L. Importance of Drug Delivery System in Steroid Aerosol Therapy via Nebulizer. Pulm Pharmacol Ther 2002; 15: 449-454.
7. TERZANO C, RICCI A, BURINSCHI V, NEKAM K, LAHOVSKY J. Comparison of the efficacy of beclomethasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma. Respir Med 2003; 97(Suppl B): S35-40.
8. TERZANO C, ALLEGRA L, BARKAI L, CREMONESI G. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. Eur Rev Med Pharmacol Sci 2001; 5: 17-24.
9. TERZANO C, BARKAI L, CREMONESI G. Corticosteroids administered by nebulization to children with bronchial asthma. Adv Ther 2001; 18: 253-260.
10. DELACOURT C, DUTAU G, LEFRANCOIS G, CLERSON P. Beclospin Clinical Development Group. Comparison of the efficacy and safety of nebulized beclomethasone dipropionate and budesonide in severe persistent childhood asthma. Respir Med 2003; 97(Suppl B): S27-33.
11. DE BENEDICTIS FM, DEL GIUDICE MM, VETRELLA M, TRESSANTI F, TRONCI A, TESTI R, DASIC G, FLIC12 STUDY GROUP. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. J Asthma 2005; 42: 331-336
12. WILLIAMS DM. Clinical considerations in the use of inhaled corticosteroids for asthma. Pharmacotherapy 2001; 21(3 Pt 2): 38S-48S.
13. LE BRUN PPH, DE BOER AH, FRULINK HW, HEUERMAN HGM. A review of the technical aspects of drug nebulization. Pharmacy World & Science 2000; 22: 75-81.
14. KENDRICK AN, SMITH EC, WILSON RSE. Selecting and using nebulizer equipment. Thorax 1997; 52(Suppl 2): S92-S101.
15. O'CALLAGHAN C, BARRY PW. The science of nebulized drug delivery. Thorax 1997; 52(Suppl 2): S31-S44.
16. TSANAKAS JN, WILSON AJ, BOON AW. Evaluation of nebulizers for bronchial challenge tests. Arch Dis Child 1987; 62: 506-508.
17. ALVINE GF, RODGERS P, FITZSIMMONS KM, AHRENS RC. Disposable jet nebulizers. How reliable are they? Chest 1992; 101: 316-319.
18. HESS D, HORNEY D, SNYDER T. Medication delivery performance of eight small volume hand held nebulizers: Effects of diluent volume, gas flow rate and nebulizer model. Respir Care 1989; 34: 717-723.
19. AROSSA W, QUAGLIOTTI F, SALA N, et al. Different performance of two commercial nebulizers. Respiration 1984; 46: 128-132.
20. KRADJAN WA, LAKSHMINARAYAN S. Efficiency of air compressor driven nebulizers. Chest 1985; 87: 512-516.
21. HOLLIE MC, MALONE RA, SKUFCA RM, NELSON HS. Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. Chest 1991; 100: 1339-1344.
22. SMITH EC, DENYER J, KENDRICK AH. Comparison of twenty three nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995; 8: 1214-1221.
23. NEWMAN SP, PELLOW PG, CLARKE SW. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers. Chest 1987; 92: 991-994.
24. JOHNSON MA, NEWMAN SP, BLOOM R, TALAEE N, CLARKE SW. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest 1989; 96: 6-10.
25. O'RIORDAN TG, WEINSTEIN MD, MAO Y. Bench Testing of nebulizers: A comparison of three methods. J Aerosol Med 1999; 12: 59-66.
26. NEWHOUSE M. The current laboratory determination of "respirable mass" is not clinically relevant. J Aerosol Med 1998; 11 (Suppl 1): S122-132.
27. FINLAY WH, STAPLETON KW, ZUBERBUHLER P. Comparisons between inhaled fine particle fractions and lung dose for nebulized aerosols. J Aerosol Med 1998; 11(Suppl 1):S65-72.
28. TANDON R, McPECK M, SMALDONE GC. Measuring nebulizer output. Chest 1997; 111: 1361-1365.
29. LOTVALL J. Inhalation therapy of the future-how will it change the way we treat asthma? J Aerosol Med 2001; 14(Suppl 1): S45-50.
30. PRITCHARD JN. The influence of lung deposition on clinical response. J Aerosol Med 2001; 14(Suppl 1): S19-26.
31. LEACH C. Targeting inhaled steroids. Int J Clin Pract Suppl 1998; 96: 23-27.
32. JANSSENS HM, DE JONGSTE JC, HOP WC, TIDDENS HA. Extra-fine particles improve lung delivery of inhaled steroids in infants: A study in an upper airway model. Chest 2003; 123: 2083-2088.
33. ARIYANANDA PL, CLARKE SW, AGNES JE. Aerosol delivery systems for bronchial asthma. Postgrad Med J 1996; 72: 151-156.
34. MORTONEN, T, YANG Y. Deposition mechanics of pharmaceutical particles in human airways. In A.J. Hickey, Editor. Inhalational Aerosols: Physical and Biological Basis for Therapy. Marcel Dekker, New York. 1996; pp 1-21.
35. THOMPSON PJ. Drug delivery to the small airways. Am J Respir Crit Care Med 1998; 157: S199-S202.